Low and Middle Income Countries Opioid Substitution Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

Description

The global Low and Middle Income Countries Opioid Substitution Therapy (OST) Market is projected to grow at a CAGR of 7.20%, increasing from US$ 855.6 million in 2025 to US$ 1,391 million by 2032. OST involves replacing illicit opioids with medically supervised alternatives like methadone or buprenorphine, reducing harm and supporting individuals in overcoming addiction. OST minimizes risks of overdose, blood-borne disease transmission, and other complications while aiding reintegration into society.

In LMICs, OST is vital for addressing public health challenges linked to opioid misuse. The market's growth is fueled by rising awareness of OST's effectiveness, international and governmental support, and innovations in service delivery. Opportunities for market players include partnerships with healthcare providers to create culturally appropriate OST solutions and leveraging telemedicine to expand access in underserved areas.

The OST market in LMICs continues to grow due to increased recognition of opioid addiction as a public health concern. Government and international organization support has bolstered OST program implementation. Market players can capitalize on opportunities by collaborating to deliver accessible, region-specific solutions and incorporating technology to enhance patient outcomes.

Market Growth Drivers

1.Recognition of Public Health Impact

Governments and international health organizations increasingly recognize the burden of opioid addiction. This has led to proactive strategies, with OST emerging as a key harm reduction tool benefiting individuals and communities.

2.Policy Support and Collaboration

Collaborative efforts between governments, NGOs, and international organizations have promoted OST adoption. Supportive policies and integration into healthcare systems ensure broader program reach and impact.

3.Rising Awareness and Healthcare Investments

Increased awareness about opioid addiction and societal impacts, along with healthcare infrastructure investments, drive market growth. Advocacy campaigns promote harm reduction strategies and OST acceptance.

Market Restraints

1.Regulatory Challenges

Diverse regulatory frameworks across LMICs create significant hurdles. Variations in licensing, medication restrictions, and government support hinder OST adoption. Harmonizing regulations is critical for market growth.

2.Implementation Barriers

Limited healthcare infrastructure and insufficient provider training challenge effective OST deployment. Addressing these barriers requires capacity-building initiatives and strategic collaborations.

Business Opportunities

1.Telemedicine Expansion

Telemedicine can improve OST access in regions with limited healthcare infrastructure. Remote consultations and support services address geographical barriers, ensuring consistent care delivery.

2.Strategic Collaborations

Partnerships with healthcare providers, NGOs, and governments can enhance OST delivery. Collaborative efforts like training programs and awareness campaigns foster sustainable healthcare ecosystems.

3.Technological Innovations

Advanced OST solutions tailored to regional needs, such as digital tools for monitoring adherence, present growth potential. Investing in technology-driven systems can improve outcomes and expand market reach.

Regional Analysis

1.Europe

Europe leads the LMICs OST market with progressive harm reduction strategies and strong healthcare systems. Evidence-based policies and collaborations ensure widespread OST adoption. Europe's focus on personalized care and harm reduction establishes it as a model for managing opioid dependence effectively.

2.South Asia and the Pacific

South Asia and the Pacific is the fastest-growing region, driven by health policies and increasing public awareness. Government initiatives, international collaborations, and recognition of OST benefits position this region for rapid expansion.

3.Latin America, Middle East & Africa

Emerging markets in these regions offer untapped opportunities. Increased government efforts and growing investments in healthcare infrastructure drive OST adoption.

Competitive Analysis

Key players in the OST Market include:

Indivior Inc.
Alkermes, Inc.
Mundipharma GmbH
Viatris Inc.
Intas Pharmaceuticals
Camurus

These companies focus on innovation, collaborations, and targeted regional strategies to strengthen their market positions.

Low and Middle Income Countries Opioid Substitution Therapy Market Segmentation

1.By Drug Class

Opioid Antagonists
Naloxone
Naltrexone
Opioid Agonists and Partial Agonists
Methadone
Buprenorphine

2.By Indication

Pain Management
Opioid Withdrawal/Opioid Use Disorder (OUD)
Alcohol De-addiction
Depression

3.By Distribution Channel

Government-supported Centers/NGOs/Tenders
Institutional Sales
Hospitals
Psychiatric Clinics
Retail Pharmacies
Online Sales

4.By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

1. Executive Summary

1.1. Global Low and Middle Income Countries Opioid Substitution Therapy Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2024
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Economic Overview
- 2.6.1. World Economic Projections
2.7. PESTLE Analysis

3. Price Analysis, 2019 - 2023

3.1. Global Average Price Analysis by Drug Class, 2019 - 2023
3.2. Prominent Factor Affecting Low and Middle Income Countries Opioid Substitution Therapy Prices
3.3. Global Average Price Analysis by Region

4. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, 2019 - 2032

4.1. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 4.1.1. Key Highlights
  - 4.1.1.1. Opioid Antagonists
  - 4.1.1.2. Naloxone
  - 4.1.1.3. Naltrexone
  - 4.1.1.4. Opioid Agonists and Partial Agonists
  - 4.1.1.5. Methadone
  - 4.1.1.6. Buprenorphine
4.2. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 4.2.1. Key Highlights
  - 4.2.1.1. Pain Management
  - 4.2.1.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
  - 4.2.1.3. Alcohol De-addiction
  - 4.2.1.4. Depression
4.3. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 4.3.1. Key Highlights
  - 4.3.1.1. Government-supported Centers/NGO's/Tenders
  - 4.3.1.2. Institutional Sales
  - 4.3.1.3. Hospitals
  - 4.3.1.4. Psychiatric clinics
  - 4.3.1.5. Retail Pharmacies
  - 4.3.1.6. Online Sales
4.4. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 4.4.1. Key Highlights
  - 4.4.1.1. North America
  - 4.4.1.2. Europe
  - 4.4.1.3. Asia Pacific
  - 4.4.1.4. Latin America
  - 4.4.1.5. Middle East & Africa

5. North America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, 2019 - 2032

5.1. North America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 5.1.1. Key Highlights
  - 5.1.1.1. Opioid Antagonists
  - 5.1.1.2. Naloxone
  - 5.1.1.3. Naltrexone
  - 5.1.1.4. Opioid Agonists and Partial Agonists
  - 5.1.1.5. Methadone
  - 5.1.1.6. Buprenorphine
5.2. North America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 5.2.1. Key Highlights
  - 5.2.1.1. Pain Management
  - 5.2.1.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
  - 5.2.1.3. Alcohol De-addiction
  - 5.2.1.4. Depression
5.3. North America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 5.3.1. Key Highlights
  - 5.3.1.1. Government-supported Centers/NGO's/Tenders
  - 5.3.1.2. Institutional Sales
  - 5.3.1.3. Hospitals
  - 5.3.1.4. Psychiatric clinics
  - 5.3.1.5. Retail Pharmacies
  - 5.3.1.6. Online Sales
- 5.3.2. Attractiveness Analysis
5.4. North America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 5.4.1. Key Highlights
  - 5.4.1.1. U.S. Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 5.4.1.2. U.S. Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 5.4.1.3. U.S. Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 5.4.1.4. Canada Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 5.4.1.5. Canada Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 5.4.1.6. Canada Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032

6. Europe Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, 2019 - 2032

6.1. Europe Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 6.1.1. Key Highlights
  - 6.1.1.1. Opioid Antagonists
  - 6.1.1.2. Naloxone
  - 6.1.1.3. Naltrexone
  - 6.1.1.4. Opioid Agonists and Partial Agonists
  - 6.1.1.5. Methadone
  - 6.1.1.6. Buprenorphine
6.2. Europe Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 6.2.1. Key Highlights
  - 6.2.1.1. Pain Management
  - 6.2.1.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
  - 6.2.1.3. Alcohol De-addiction
  - 6.2.1.4. Depression
6.3. Europe Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 6.3.1. Key Highlights
  - 6.3.1.1. Government-supported Centers/NGO's/Tenders
  - 6.3.1.2. Institutional Sales
  - 6.3.1.3. Hospitals
  - 6.3.1.4. Psychiatric clinics
  - 6.3.1.5. Retail Pharmacies
  - 6.3.1.6. Online Sales
- 6.3.2. Attractiveness Analysis
6.4. Europe Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 6.4.1. Key Highlights
  - 6.4.1.1. Germany Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.2. Germany Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.3. Germany Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.4. U.K. Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.5. U.K. Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.6. U.K. Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.7. France Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.8. France Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.9. France Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.10. Italy Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.11. Italy Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.12. Italy Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.13. Turkey Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.14. Turkey Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.15. Turkey Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.16. Russia Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.17. Russia Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.18. Russia Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.19. Rest of Europe Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.20. Rest of Europe Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 6.4.1.21. Rest of Europe Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032

7. Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, 2019 - 2032

7.1. Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 7.1.1. Key Highlights
  - 7.1.1.1. Opioid Antagonists
  - 7.1.1.2. Naloxone
  - 7.1.1.3. Naltrexone
  - 7.1.1.4. Opioid Agonists and Partial Agonists
  - 7.1.1.5. Methadone
  - 7.1.1.6. Buprenorphine
7.2. Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 7.2.1. Key Highlights
  - 7.2.1.1. Pain Management
  - 7.2.1.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
  - 7.2.1.3. Alcohol De-addiction
  - 7.2.1.4. Depression
7.3. Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 7.3.1. Key Highlights
  - 7.3.1.1. Government-supported Centers/NGO's/Tenders
  - 7.3.1.2. Institutional Sales
  - 7.3.1.3. Hospitals
  - 7.3.1.4. Psychiatric clinics
  - 7.3.1.5. Retail Pharmacies
  - 7.3.1.6. Online Sales
- 7.3.2. Attractiveness Analysis
7.4. Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 7.4.1. Key Highlights
  - 7.4.1.1. China Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.2. China Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.3. China Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.4. Japan Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.5. Japan Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.6. Japan Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.7. South Korea Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.8. South Korea Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.9. South Korea Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.10. India Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.11. India Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.12. India Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.13. Southeast Asia Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.14. Southeast Asia Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.15. Southeast Asia Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.16. Rest of Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.17. Rest of Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 7.4.1.18. Rest of Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032

8. Latin America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, 2019 - 2032

8.1. Latin America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 8.1.1. Key Highlights
  - 8.1.1.1. Opioid Antagonists
  - 8.1.1.2. Naloxone
  - 8.1.1.3. Naltrexone
  - 8.1.1.4. Opioid Agonists and Partial Agonists
  - 8.1.1.5. Methadone
  - 8.1.1.6. Buprenorphine
8.2. Latin America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 8.2.1. Key Highlights
  - 8.2.1.1. Pain Management
  - 8.2.1.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
  - 8.2.1.3. Alcohol De-addiction
  - 8.2.1.4. Depression
8.3. Latin America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 8.3.1. Key Highlights
  - 8.3.1.1. Government-supported Centers/NGO's/Tenders
  - 8.3.1.2. Institutional Sales
  - 8.3.1.3. Hospitals
  - 8.3.1.4. Psychiatric clinics
  - 8.3.1.5. Retail Pharmacies
  - 8.3.1.6. Online Sales
- 8.3.2. Attractiveness Analysis
8.4. Latin America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 8.4.1. Key Highlights
  - 8.4.1.1. Brazil Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 8.4.1.2. Brazil Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 8.4.1.3. Brazil Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 8.4.1.4. Mexico Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 8.4.1.5. Mexico Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 8.4.1.6. Mexico Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 8.4.1.7. Argentina Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 8.4.1.8. Argentina Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 8.4.1.9. Argentina Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 8.4.1.10. Rest of Latin America Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 8.4.1.11. Rest of Latin America Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 8.4.1.12. Rest of Latin America Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032

9. Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, 2019 - 2032

9.1. Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 9.1.1. Key Highlights
  - 9.1.1.1. Opioid Antagonists
  - 9.1.1.2. Naloxone
  - 9.1.1.3. Naltrexone
  - 9.1.1.4. Opioid Agonists and Partial Agonists
  - 9.1.1.5. Methadone
  - 9.1.1.6. Buprenorphine
9.2. Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 9.2.1. Key Highlights
  - 9.2.1.1. Pain Management
  - 9.2.1.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
  - 9.2.1.3. Alcohol De-addiction
  - 9.2.1.4. Depression
9.3. Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 9.3.1. Key Highlights
  - 9.3.1.1. Government-supported Centers/NGO's/Tenders
  - 9.3.1.2. Institutional Sales
  - 9.3.1.3. Hospitals
  - 9.3.1.4. Psychiatric clinics
  - 9.3.1.5. Retail Pharmacies
  - 9.3.1.6. Online Sales
- 9.3.2. Attractiveness Analysis
9.4. Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
- 9.4.1. Key Highlights
  - 9.4.1.1. GCC Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 9.4.1.2. GCC Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 9.4.1.3. GCC Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 9.4.1.4. South Africa Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 9.4.1.5. South Africa Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 9.4.1.6. South Africa Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 9.4.1.7. Egypt Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 9.4.1.8. Egypt Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 9.4.1.9. Egypt Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 9.4.1.10. Nigeria Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 9.4.1.11. Nigeria Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 9.4.1.12. Nigeria Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 9.4.1.13. Rest of Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 9.4.1.14. Rest of Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
  - 9.4.1.15. Rest of Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032

10. Competitive Landscape

10.1. By Solution Type vs by Indication Heatmap
10.2. Company Market Share Analysis, 2024
10.3. Competitive Dashboard
10.4. Company Profiles
- 10.4.1. Indivior Inc.
  - 10.4.1.1. Company Overview
  - 10.4.1.2. Product Portfolio
  - 10.4.1.3. Financial Overview
  - 10.4.1.4. Business Strategies and Development
- 10.4.2. Alkermes, Inc
  - 10.4.2.1. Company Overview
  - 10.4.2.2. Product Portfolio
  - 10.4.2.3. Financial Overview
  - 10.4.2.4. Business Strategies and Development
- 10.4.3. Mundipharma GmbH
  - 10.4.3.1. Company Overview
  - 10.4.3.2. Product Portfolio
  - 10.4.3.3. Financial Overview
  - 10.4.3.4. Business Strategies and Development
- 10.4.4. Viatris Inc
  - 10.4.4.1. Company Overview
  - 10.4.4.2. Product Portfolio
  - 10.4.4.3. Financial Overview
  - 10.4.4.4. Business Strategies and Development
- 10.4.5. Intas Pharmaceuticals
  - 10.4.5.1. Company Overview
  - 10.4.5.2. Product Portfolio
  - 10.4.5.3. Financial Overview
  - 10.4.5.4. Business Strategies and Development
- 10.4.6. Camurus
  - 10.4.6.1. Company Overview
  - 10.4.6.2. Product Portfolio
  - 10.4.6.3. Financial Overview
  - 10.4.6.4. Business Strategies and Development

11. Appendix

11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations